Corient Capital Partners, LLC Amgen Inc Transaction History

Corient Capital Partners, LLC

$1.34 Billion
Q3 2022

A detailed history of Corient Capital Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Corient Capital Partners, LLC holds 26,680 shares of AMGN stock, worth $7.86 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

26,680

Previous 26,680 -0.0%

Holding current value

$7.86 Million

Previous $6.49 Million -0.0%

% of portfolio

0.49%

Previous 0.49%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $534,324 - $594,609	2,316 Added 9.51%	26,680 $6.49 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $305,223 - $337,657	1,392 Added 6.06%	24,364 $5.89 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $1.48 Million - $1.69 Million	-7,434 Reduced 24.45%	22,972 $5.17 Million
Q3 2021 Nov 16, 2021	BUY	$212.27 - $248.7 $115,687 - $135,541	545 Added 1.83%	30,406 $6.47 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $392,881 - $435,873	1,682 Added 5.97%	29,861 $7.28 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $198,387 - $231,188	894 Added 3.28%	28,179 $7.01 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $140,430 - $167,227	649 Added 2.44%	27,285 $6.27 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $122,018 - $135,694	-520 Reduced 1.91%	26,636 $6.77 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $471,183 - $578,206	-2,382 Reduced 8.06%	27,156 $6.41 Million
Q1 2020 May 06, 2020	BUY	$182.24 - $241.7 $410,040 - $543,825	2,250 Added 8.25%	29,538 $5.99 Million
Q4 2019 Feb 04, 2020	BUY	$189.21 - $243.2 $518,246 - $666,124	2,739 Added 11.16%	27,288 $6.58 Million
Q3 2019 Nov 06, 2019	BUY	$174.11 - $208.62 $49,795 - $59,665	286 Added 1.18%	24,549 $4.75 Million
Q2 2019 Aug 08, 2019	SELL	$166.7 - $195.41 $422,251 - $494,973	-2,533 Reduced 9.45%	24,263 $4.47 Million
Q1 2019 May 10, 2019	SELL	$180.87 - $203.88 $1.4 Million - $1.58 Million	-7,764 Reduced 22.47%	26,796 $5.09 Million
Q4 2018 Feb 07, 2019	SELL	$178.4 - $208.25 $229,779 - $268,226	-1,288 Reduced 3.59%	34,560 $6.73 Million
Q2 2018 Oct 02, 2018	SELL	$166.05 - $186.51 $54,630 - $61,361	-329 Reduced 0.91%	35,848 $6.62 Million
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $76,751 - $89,694	-453 Reduced 1.24%	36,177 $6.17 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $4.9 Million - $5.48 Million	29,051 Added 383.31%	36,630 $6.37 Million
Q3 2017 Nov 14, 2017	SELL	$167.29 - $191.0 $964,426 - $1.1 Million	-5,765 Reduced 43.2%	7,579 $0
Q2 2017 Aug 14, 2017	BUY	N/A	227 Added 1.73%	13,344 $2.3 Million
Q1 2017 Aug 17, 2017	BUY	N/A	4,865 Added 58.96%	13,117 $2.15 Million
Q1 2017 Aug 14, 2017	BUY	N/A	8,252	8,252 $297,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corient Capital Partners, LLC with notifications on news.

Account

Corient Capital Partners, LLC Amgen Inc Transaction History